Combined aortic and mitral stenosis in mucopolysaccharidosis type I-S (Ullrich-Scheie syndrome)

T A Fischer1, H A Lehr, U Nixdorff

  • 1Department of Medicine II, University of Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany.

Insights

Mucopolysaccharidosis (MPS) syndromes can cause severe heart valve disease. This case highlights rare combined aortic and mitral stenosis in MPS type I-S, emphasizing the need for surgical intervention.

Area of Science:

  • Cardiology
  • Genetics
  • Metabolic Disorders

Background:

  • Mucopolysaccharidosis (MPS) syndromes are rare genetic metabolic disorders.
  • Cardiac involvement, particularly left-sided valvar heart disease, is a known complication of MPS types I and VI.
  • Surgical intervention for valvar heart disease in MPS patients is infrequently reported.

Observation:

  • A 35-year-old male patient with MPS type I-S presented with severe mitral valve stenosis.
  • This occurred subsequent to a successful surgical aortic valve replacement for aortic stenosis.
  • The patient exhibited characteristic cardiac and extracardiac abnormalities associated with MPS type I-S.

Findings:

  • Histomorphological analysis revealed irregular valve thickening, fibrosis, and calcification in the affected mitral valve.
  • Cardiac ultrasound and left heart catheterization confirmed severe mitral valve stenosis.
  • This case represents a rare instance of combined aortic and mitral stenosis in MPS type I-S.

Implications:

  • Successful surgical management of complex valvar heart disease in MPS is feasible.
  • Early recognition and intervention for cardiac manifestations in MPS are crucial.
  • This case underscores the significant impact of MPS on cardiovascular health and the importance of specialized care.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...